Alzamend Neuro, Inc.

ALZN

Exchange: Nasdaq
Industry: Pharmaceutical Preparations
SEC CIK: 0001677077

SEC filings (opens in a new tab)

In the last 90 days, Alzamend Neuro, Inc. insiders filed 1 open-market purchase and 1 sale; 12 institutions reported holding it in 13F filings for Q2 2026, worth $3.26M in total; no superinvestor holds it.

Q4 2022 vs. Q3 2022

How the institutions holding Alzamend Neuro, Inc. changed between Q3 2022 and Q4 2022.

All holders in Q4 2022 All holders in Q3 2022

13F holders of ALZN: Q3 2022 compared with Q4 2022
Measure	Q3 2022	Q4 2022	Change
Holders	17	33	+16
Shares	7.94M	6.99M	−948.0K (−11.9%)
Value	$9.41M	$3.98M	−$5.43M (−57.7%)

New holders (18)

Institutions that held Alzamend Neuro, Inc. at the end of Q4 2022 but not at the end of Q3 2022.

Institutions new to ALZN in Q4 2022
Institution	Shares	Value	% of portfolio
Virtu Financial LLC	62,660	$35.0K	0.00%
HRT Financial LP	57,080	$32.0K	0.00%
Charles Schwab Investment Management Inc	53,080	$30.0K	0.00%
Renaissance Technologies LLC	49,800	$28.0K	0.00%
Bank of New York Mellon Corp	40,367	$22.8K	0.00%
Susquehanna International Group, LLP	35,513	$20.1K	0.00%
Two Sigma Securities, LLC	35,064	$19.8K	0.00%
State Street Corp	31,900	$18.0K	0.00%
Ergoteles LLC	23,574	$13.3K	0.00%
Two Sigma Investments, LP	19,313	$10.9K	0.00%
Tower Research Capital LLC (TRC)	16,941	$10.0K	0.00%
Cubist Systematic Strategies, LLC	16,400	$9.26K	0.00%
Freedom Wealth Alliance, LLC	15,000	$8.47K	0.01%
Jane Street Group, LLC	13,651	$7.71K	0.00%
Ground Swell Capital, LLC	13,619	$7.69K	0.03%
Centaurus Financial, Inc.	12,000	$7.00K	0.00%
StoneX Group Inc.	11,005	$6.22K	0.00%
IFP Advisors, Inc	6,000	–	–

Sold out (2)

Institutions that held Alzamend Neuro, Inc. at the end of Q3 2022 and filed for Q4 2022 without it.

Institutions that sold out of ALZN in Q4 2022
Institution	Shares, Q3 2022	Value, Q3 2022
Dark Forest Capital Management LP	11,344	$13.0K
Benjamin Edwards Inc	1,000	$1.00K